MELNICK DAVID A. (Chief Medical Officer) received a stock award from SPERO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/3/2022ACC: 0000899243-22-004594
Officer· Chief Medical Officer
Since Jan 2019
+91.20K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
91.20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+38.01K
Price / share
—
Trade value
—
% of position
158.0%
2/1/2022
24.07K→62.08K
Total
Net shares
+38.01K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/1/2022 | A · Award | +38.01K | — | — | 158.0% | 24.07K | 62.08K |
| Total | +38.01K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
53.19K shares
Shares
+53.19K
Strike price
11.18
Held after
53.19K
Exercisable
—
2/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock53.19K shares | 2/1/2022 | A · Award | +53.19K | 11.18 | — | 53.19K |